← Leaderboards
Jervaughn D Hunter
University Of California, San Diego
$62,664
Attributed
$62,664
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $39.7K · FY2022–23$50K$37.5K$25K$12.5K$0
'22
'23
Funding mix
By agency
NIH$62,664 · 1
By mechanism
F31$62,664 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Diego
Same institution · by research overlap
- Mark H Tuszynski$42,403,260
- Juan Carlos Del Alamo$4,825,213
- Yacov Koffler$973,148
- Steven Lee Wagner$8,475,404
- Daniela Valdez-Jasso$1,884,844
Others in their field
Other Rising Stars on “Efficacy Evaluation”
- Angee Greer · Ppd Development Lp$82,531,927
- Christina Millin · Rho Federal Systems Division, Inc.$31,828,916
- Sabrina Paganoni · Massachusetts General Hospital$26,348,733
- Suma Babu · Massachusetts General Hospital$26,348,733
- Kevin Saunders · Duke University$18,106,404
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
Research focus
Efficacy EvaluationEfficacy StudyAdverse EventApoptosisAnimalsBehaviorBiochemicalAngiogenesisCardiacCardiac MyocytesCardiac RepairCardiovascular SystemCell BehaviorCellsCell TherapyCell TypeCombinatorialBlood VesselsCongenital Heart DefectsCustomDefectDesignEchocardiographyEncapsulated
Grant awards (2)
Investigation of a Right Ventricle Based Decellularized Extracellular Matrix Hydrogel and Cardiac Progenitor Cells as a Treatment for Right Ventricular Heart Failure$22,983
F31 · FY2023 · HL · contact PI
Investigation of a Right Ventricle Based Decellularized Extracellular Matrix Hydrogel and Cardiac Progenitor Cells as a Treatment for Right Ventricular Heart Failure$39,681
F31 · FY2022 · HL · contact PI